Semperit Aktiengesellschaft Holding (SEM)
Vienna Exchange · Austria · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 18.70 |
|---|---|
| 52-week range | 11.20 – 19.80 |
| Return, 1 month / 3 months | +1.4% / +23.8% |
| Return, 1 year / 3 years | +41.7% / +28.3% |
| Trend | Uptrend |
| RSI (14) | 48 |
| Volatility (1 year) | 33.5% |
| Worst drawdown (1 year) | -14.9% |
| Average daily value traded | 0.15M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Semperit Aktiengesellschaft Holding is an Austrian industrial company that makes rubber and plastic products for industrial and medical uses. Its industrial range includes conveyor belts, hoses, seals and moulded rubber parts supplied to machinery, mining, construction and manufacturing customers. The company also produces medical and hygiene products such as examination gloves and related items for healthcare and laboratory markets. It is based in Austria and serves customers in many countries.
The shares are listed on the Vienna Exchange in Austria under the code SEM, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Semperit Aktiengesellschaft Holding (SEM) trades on the Vienna Exchange in Austria. It last closed at EUR 18.70 on 22 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 4 of 84 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 41.7% and over the last three months it rose 23.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Vienna Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 87 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 22.4% | ||
| From 52-week high | -5.6% | ||
| Momentum | 83 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 23.8% | ||
| 6-month return | 25.5% | ||
| 12-month return, skipping the last month | 39.8% | ||
| Stability (higher is calmer) | 60 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.9% | ||
| Liquidity | 63 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.15M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −2.1% |
|---|---|
| 1 month | +1.4% |
| 3 months | +23.8% |
| 6 months | +25.5% |
| 1 year | +41.7% |
| 3 years | +28.3% |
| 5 years | −7.1% |
Signals
| 50-day / 200-day average | 18.22 / 15.28 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.58 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Apr 2025 | EUR 0.5000 |
| 25 Apr 2024 | EUR 0.5000 |
| 11 Sep 2023 | EUR 3.0000 |
| 27 Apr 2023 | EUR 1.5000 |
| 2 May 2022 | EUR 1.5000 |
| 29 Apr 2021 | EUR 1.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Vienna Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.